Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Pediatr. Sep 9, 2023; 12(4): 220-229
Published online Sep 9, 2023. doi: 10.5409/wjcp.v12.i4.220
Published online Sep 9, 2023. doi: 10.5409/wjcp.v12.i4.220
Safety and efficacy of intravitreal anti vascular endothelial growth factor for severe posterior retinopathy of prematurity with flat fibrovascular proliferation
Puja Maitra, Subramaniam Prema, Venkatapathy Narendran, Parag K Shah, Pediatric Retina and Ocular Oncology, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Coimbatore 641014, Tamil Nadu, India
Author contributions: Shah PK and Narendran V designed the research study; Maitra P and Prema S performed the research; Narendran V contributed towards analytic tools; Maitra P, Prema S and Shah PK analyzed the data and wrote the manuscript; All authors have read and approve the final manuscript.
Institutional review board statement: The study was reviewed and approved by the Aravind Eye Hospital Institutional Ethics Committee (Approval No. RET201300423).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: We have no financial relationships to disclose.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at email address: drshahpk2002@yahoo.com. Participants gave informed consent for data sharing.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Parag K Shah, DNB, Professor, Pediatric Retina & Ocular Oncology, Aravind Eye Hospital, Avinashi Road, Coimbatore 641014, Tamil Nadu, India. drshahpk2002@yahoo.com
Received: May 5, 2023
Peer-review started: May 5, 2023
First decision: June 19, 2023
Revised: June 26, 2023
Accepted: July 7, 2023
Article in press: July 7, 2023
Published online: September 9, 2023
Processing time: 123 Days and 16.3 Hours
Peer-review started: May 5, 2023
First decision: June 19, 2023
Revised: June 26, 2023
Accepted: July 7, 2023
Article in press: July 7, 2023
Published online: September 9, 2023
Processing time: 123 Days and 16.3 Hours
Core Tip
Core Tip: This is a retrospective study to evaluate if anti-vascular endothelial growth factor injection could cause contraction of preexisting fibrovascular proliferation when present in severe retinopathy of prematurity.